Long-term therapy with clevudine for chronic hepatitis B can be associated with myopathy characterized by depletion of mitochondrial DNA.

MLA

Seok, Jung Im, et al. “Long-Term Therapy with Clevudine for Chronic Hepatitis B Can Be Associated with Myopathy Characterized by Depletion of Mitochondrial DNA.” Hepatology (Baltimore, Md.), vol. 49, no. 6, June 2009, pp. 2080–86. EBSCOhost, https://doi.org/10.1002/hep.22959.

APA

Seok, J. I., Lee, D. K., Lee, C. H., Park, M. S., Kim, S. Y., Kim, H.-S., Jo, H.-Y., Lee, C. H., & Kim, D.-S. (2009). Long-term therapy with clevudine for chronic hepatitis B can be associated with myopathy characterized by depletion of mitochondrial DNA. Hepatology (Baltimore, Md.), 49(6), 2080–2086. https://doi.org/10.1002/hep.22959

Chicago

Seok, Jung Im, Dong Kuck Lee, Chang Hyeong Lee, Min Su Park, Sun Young Kim, Hyang-Sook Kim, Hee-Young Jo, Chang Hun Lee, and Dae-Seong Kim. 2009. “Long-Term Therapy with Clevudine for Chronic Hepatitis B Can Be Associated with Myopathy Characterized by Depletion of Mitochondrial DNA.” Hepatology (Baltimore, Md.) 49 (6): 2080–86. doi:10.1002/hep.22959.